Epidemiological Characteristics and Etiology of Budd-Chiari Syndrome in Upper Egypt

References

• EASL. Clinical practice guidelines. Vascular diseases of the liver. J Hepatol. 2016;64(1):179–202. doi:10.1016/j.jhep.2015.07.04026516032
   PubMed Web of Science ®Google Scholar
• Valla DC. Primary Budd-Chiari syndrome. J Hepatol. 2009;50(1):195–203. doi:10.1016/j.jhep.2008.10.00719012988
   PubMed Web of Science ®Google Scholar
• Wang ZG, Jones RS. Budd-Chiari syndrome. Curr Probl Surg. 1996;33(2):83–211. doi:10.1016/S0011-3840(96)80001-38595784
   PubMed Web of Science ®Google Scholar
• Afredj N, Guessab N, Nani A, et al. Aetiological factors of Budd-Chiari syndrome in Algeria. World J Hepatol. 2015;7(6):903–909. doi:10.4254/wjh.v7.i6.90325937867
   PubMedGoogle Scholar
• Qi X, Han G, Guo X, et al. Review article: the aetiology of primary Budd–Chiari syndrome—differences between the West and China. Aliment Pharmacol Ther. 2016;44(11–12):1152–1167. doi:10.1111/apt.1381527734511
   PubMed Web of Science ®Google Scholar
• Valla D. Budd–Chiari syndrome/hepatic venous outflow tract obstruction. Hepatol Int. 2017;12(S1):168–180. doi:10.1007/s12072-017-9810-528685257
   PubMed Web of Science ®Google Scholar
• Baxter EJ, Scott M, Campbell PJ, et al. Cancer genome project: acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365(9464):1054–1061. doi:10.1016/S0140-6736(05)71142-915781101
   PubMed Web of Science ®Google Scholar
• International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335(8697):1078–1080.1970380
   PubMed Web of Science ®Google Scholar
• Martens P, Nevens F. Budd–Chiari syndrome. United European Gastroenterol J. 2015;3(6):489–500. doi:10.1177/2050640615582293
   Web of Science ®Google Scholar
• Valla DC. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis. 2002;22(1):5–14. doi:10.1055/s-2002-2320211928075
   PubMed Web of Science ®Google Scholar
• Sakr MA, Abdelhakam SM, Dabbous HM, et al. Pattern of vascular involvement in egyptian patients with Budd-Chiari syndrome: relation to etiology and impact on clinical presentation epidemiological aspects of Budd-Chiari in Egyptian patients: a single-center study. Ann Hepatol. 2018;17(4):638–644. doi:10.5604/01.3001.0012.093329893705
   PubMed Web of Science ®Google Scholar
• Lin M, Zhang F, Wang Y, et al. Liver cirrhosis caused by chronic Budd–Chiari syndrome. Medicine. 2017;96(34):34. doi:10.1097/MD.0000000000007425
   Web of Science ®Google Scholar
• Dutta AK, Chacko A, George B, Joseph JA, Nair SC, Mathews V. Risk factors of thrombosis in abdominal veins. World J Gastroenterol. 2008;14(28):4518–4522. doi:10.3748/wjg.14.451818680232
   PubMed Web of Science ®Google Scholar
• Sakr M, Barakat E, Abdelhakam S, et al. Epidemiological aspects of Budd–Chiari in Egyptian patients: a single-center study. World J Gastroenterol. 2011;17(42):4704–4710. doi:10.3748/wjg.v17.i42.470422180713
   PubMed Web of Science ®Google Scholar
• Dilawari JB, Bambery P, Chawla Y, et al. Hepatic outflow obstruction (Budd–Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore). 1994;73(1):21–36. doi:10.1097/00005792-199401000-000038309360
   PubMed Web of Science ®Google Scholar
• Bayraktar UD, Seren S, Bayraktar Y. Hepatic venous outflow obstruction: three similar syndromes. World J Gastroenterol. 2007;13(13):1912–1927. doi:10.3748/wjg.v13.i13.191217461490
   PubMed Web of Science ®Google Scholar
• Dayal S, Pati HP, Pande GK, Sharma MP, Saraya AK. Multilineage hemopoietic stem cell defects in Budd Chiari syndrome. J Hepatol. 1997;26(2):293–297. doi:10.1016/S0168-8278(97)80044-X9059949
   PubMed Web of Science ®Google Scholar
• Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India. Hepatology. 2001;34(4):666–670. doi:10.1053/jhep.2001.2794811584361
   PubMed Web of Science ®Google Scholar
• Uskudar O, Akdogan M, Sasmaz N, Yilmaz S, Tola M, Sahin B. Etiology and portal vein thrombosis in Budd-Chiari syndrome. World J Gastroenterol. 2008;14(18):2858–2862. doi:10.3748/wjg.14.285818473410
   PubMed Web of Science ®Google Scholar
• Darwish MS, Plessier A, Hernandez-Guerra M, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 2009;151(3):167–175. doi:10.7326/0003-4819-151-3-200908040-0000419652186
   PubMed Web of Science ®Google Scholar
• Seijo S, Plessier A, Hoekstra J, et al. Good long-term outcome of Budd–Chiari syndrome with a step-wise management. Hepatology. 2013;57(5):1962–1968. doi:10.1002/hep.2630623389867
   PubMed Web of Science ®Google Scholar
• Espinosa G, Font J, Garcia-Pagan JC, et al. Budd–Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients. Medicine (Baltimore). 2001;80(6):345–354. doi:10.1097/00005792-200111000-0000111704712
   PubMed Web of Science ®Google Scholar
• Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA. 1994;91(4):1396–1400. doi:10.1073/pnas.91.4.13968108421
   PubMed Web of Science ®Google Scholar
• El Sebay HM, Safan MA, Daoud AA, Tayel SI, Nouh MA, El Shafie S. Association of factor V Leiden, Janus kinase 2, prothrombin, and MTHFR mutations with primary Budd–Chiari syndrome in Egyptian patients. J Gastroenterol Hepatol. 2016;31(1):235–240. doi:10.1111/jgh.1306626238013
   PubMed Web of Science ®Google Scholar
• Qi X, Wu F, Ren W, et al. Thrombotic risk factors in Chinese Budd-Chiari syndrome patients. An observational study with a systematic review of the literature. Thromb Haemost. 2013;109(05):878–884. doi:10.1160/TH12-10-078423447059
   PubMed Web of Science ®Google Scholar
• Wang H, Sun G, Zhang P, et al. JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients. J Gastroenterol Hepatol. 2014;29(1):208–214. doi:10.1111/jgh.1237923980667
   PubMed Web of Science ®Google Scholar
• Li J, Temmerman M, Chen Q, Xu J, Hu L, Zhang WH. A review of contraceptive practices among married and unmarried women in China from 1982 to 2010. Eur J Contracept Reprod Health Care. 2013;18(3):148–158. doi:10.3109/13625187.2013.77667323544865
   PubMed Web of Science ®Google Scholar
• Skouby SO. Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries. Eur J Contracept Reprod Health Care. 2010;15(Suppl 2):S42–S53. doi:10.3109/13625187.2010.53300221091166
   PubMed Web of Science ®Google Scholar
• DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009;49:1729–1764.19399912
   PubMed Web of Science ®Google Scholar
• Senzolo M, Riggio O, Primignani M. Vascular disorders of the liver: recommendations from the Italian association for the study of the liver (AISF) ad hoc committee. Dig Liver Dis. 2011;43(7):503–514. doi:10.1016/j.dld.2010.11.00621185794
   PubMedGoogle Scholar
• Poddar P, Gurizala S, Rao S. Endovascular stenting of IVC using Brockenborough’s needle in Budd–Chiari syndrome—a case report. Indian Heart J. 2014;66(3):363–365. doi:10.1016/j.ihj.2014.03.01424973846
   PubMedGoogle Scholar
• Darwish MS, Valla DC, de Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology. 2004;39(2):500–508. doi:10.1002/hep.2006414768004
   PubMed Web of Science ®Google Scholar
• Deltenre P, Denninger MH, Hillaire S, et al. Factor V Leiden related Budd-Chiari syndrome. Gut. 2001;48(2):264–268. doi:10.1136/gut.48.2.26411156651
   PubMed Web of Science ®Google Scholar
• Valla DC. Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West. J Gastroenterol Hepatol. 2004;19(s7):S204–S211. doi:10.1111/j.1440-1746.2004.03642.x
   Google Scholar